In conclusion, to the best of our knowledge, this is the first work that describes an anti-cancer molecule, Oxy, that in addition to acting as an AI, also modulates both ERs and AR acting as an ERα antagonist and AR agonist, rendering Oxy a more effective anti-tumor profile. This evidence concerns the gene ESR1 and neoplasm.